Nicole Zurcher Wimmer, PhD, uses magnetic resonance (MR) and positron emission tomography (PET) to study brain function and dysfunction in health and disease with an emphasis on neurodevelopmental disorders. Her main research focus is on autism spectrum disorder and related conditions, which she has been studying for over a decade. In the context of collaborative work with investigators at the Healey Center at Massachusetts General Hospital, she has investigated potential biomarkers for amyotrophic lateral sclerosis and other motor neuron diseases.
PhD in Neuroscience, Ecole Polytechnique Federale de Lausanne
1. Gilbert TM, Zürcher NR, Catanese MC, Tseng CJ, Di Biase MA, Lyall AE, Hightower BG, Parmar AJ, Bhanot A, Wu CJ, Hibert ML, Kim M, Mahmood U, Stufflebeam SM, Schroeder FA, Wang C, Roffman JL, Holt DJ, Greve DN, Pasternak O, Kubicki M, Wey HY, Hooker JM. Neuroepigenetic signatures of age and sex in the living human brain. Nat Commun. 2019 Jul 3;10(1):2945.
2. Zürcher NR, Bhanot A, McDougle CJ, Hooker JM. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities. Neurosci Biobehav Rev. 2015 May;52:56-73.
3. Zürcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin. 2015 Jan 19;7:409-14.
Autism Speaks Meixner Translational Postdoctoral Fellowship, Autism Speaks, 2014-2016
Department Award, Radiology, Clinical Research Day, Massachusetts General Hospital, 2014
Translational Research Award (co-author), sponsored by Molecular Biology, Clinical Research Day, Massachusetts General Hospital, 2015